NEW YORK (TheStreet) -- CHANGE IN RATINGS
rated new Neutral at Susquehanna. $12 price target. Company lacks visibility to suggest sustainable execution.
rated new Hold at Jefferies. BSX was initiated with a Hold rating. $7 price target. It will take time for the new management team to generate growth outside of the slowing core businesses.
upgraded at Goldman to Buy. $44 price target. Expect more cost cuts, which could boost margins.
upgraded at Morgan Stanley for Equal-weight to Overweight. $44 price target. Company will benefit from increased demand for multi-function network security.
rated new Buy at Kaufman. $59 price target. Company is a market leader and can gain more share in the coming years.
rated new Outperform at Oppenheimer. $40 price target. Company should benefit from more constructive regulation in California.
upgraded at Citigroup from Hold to Buy. $40 price target. Qualitest acquisition makes strategic and financial sense.
upgraded at Oppenheimer from Perform to Outperform. $40 price target. Qaulitest purchase should add 40 cents to annual earnings.
( JCG) downgraded at Janney from Buy to Neutral. $37 price target. Company is facing increased competition.
Las Vegas Sands
rated new Market Perform at Wells. Company continues to grow and the market is already pricing in a lot of bad news for Las Vegas.
rated new Hold at Jefferies. $36 price target. Company is seeing slower growth in its core businesses.
rated new Buy at Goldman. $56 price target. Company is in the early stages of turning its margins around.
rated new Buy at MKM Partners. $50 price target. Company will deliver strong margins, despite lower natural gas prices.
downgraded at Credit Suisse to Underperform from Neutral. Valuation call, stock is already pricing in higher fertilizer prices, Credit Suisse said. Price target lifted to $41 from $36.
rated new Neutral at Ladenburg. $63 price target. Company should raise its dividend, but already trades at a premium valuation.
rated new Outperform at Wells Fargo. Company should gain market share and continue to expand margins.
rated new Outperform at Wells Fargo. Wynn Macau continues to perform well and gaming could soon come to Japan.
STOCK COMMENTS / EPS CHANGES
estimate tweaked at Barclays. ACN 2011 EPS estimate raised by a penny to $2.99, 2010 maintained at $2.62. Upcoming 4Q10 results should show decent margin expansion and reassurance on client budgets. Maintain Overweight rating and $48 price target.
price target boosted at Barclays to $180 from $132.Reiterate AMZN's Overweight rating on solid ecommerce trends and strong Kindle sales. 2010 and 2011 EPS estimates lifted to $2.54 and $3.39, respectively.
target raised at MKM to $24. Fear of a double-dip recession has waned.
target boosted at FBR. Shares of CR now seen reaching $41. Company is seeing better aerospace demand.
estimates increased at UBS through 2011. Buyback program should add to earnings. Neutral rating and $44 price target.
estimate higher at Barclays. HPQ 2011 EPS estimate improved to $5.10, 2010 held at $4.51. More focus on growth & innovation. Reiterate Overweight rating and $50 price target.
target raised at Kaufman. Shares of HPQ now seen reaching $53. Company is seeing better demand for enterprise hardware.
estimates boosted at UBS through 2012. Company boosted guidance and is realizing higher margins. Buy rating and $19 price target.
target reduced at Goldman to $64, Goldman Sachs said. Smartstax is not performing as well in the crops. Buy rating.
( MOT) target, estimates boosted at Barclays. MOT price target raised a dollar to $10 on steady android progress in 2H10. 2010 and 2011 EPS estimates lifted to $0.41 and $0.54, respectively. Maintain Overweight rating.
numbers cut at Goldman. Shares of MS now seen reaching $30. Estimates also reduced, given lower trading activity. Neutral rating.
price target raised at BofA/Merrill by $3 to $65. Bank of America/Merrill Lynch likes the strong Bakken oil results and the company's ability to grow while showing spending discipline. Maintain Buy rating.
numbers upped at Citigroup. NIHD estimates were boosted through $55. Recent management meeting suggests that the company can exceed near-term expectations. Buy rating.
estimates raised at Credit Suisse. PAYX 2011 and 2012 EPS estimates raised to $1.36 and $1.50, respectively, following strong 1Q11 results. Maintain Neutral rating and $28 price target.
numbers increased at Citigroup through 2012. Company continues to benefit from cost-cutting. Buy rating and new $38 price target.
estimates raised at Citigroup through 2012. Company is expanding its gross margin. Sell rating and $31 price target.
This article was written by a staff member of TheStreet.